Paper41540253
The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans.
Christen S and 11 others. Nat Metab, 2026. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Papers, record 41540253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41540253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| NAD | Major topic |
| Niacinamide | Major topic |
| Nicotinamide Mononucleotide | Major topic |
| Humans | |
| Adult | |
| Male | |
| Female | |
| Pyridinium Compounds | |
| Niacin | |
| Middle Aged | |
| Microbiota | |
| Young Adult | |
| Dietary Supplements |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05517122 | Effect of Oral NAD+ Precursors Administration on Blood NAD+ Concentration in Healthy Adults | Derived from the trial | Yes |
Source ClinicalTrials.gov
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9748331 | The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries. | Biochemistry | 1998 | https://conductscience.org/library/papers/9748331 | PubMed |
| 2 | 34799586 | BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities. | Nat Commun | 2021 | https://conductscience.org/library/papers/34799586 | PubMed |
| 3 | 39026037 | Regulation of and challenges in targeting NAD+ metabolism. | Nat Rev Mol Cell Biol | 2024 | https://conductscience.org/library/papers/39026037 | PubMed |
| 4 | 16448051 | XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. | Anal Chem | 2006 | https://conductscience.org/library/papers/16448051 | PubMed |
| 5 | 34041853 | NAD+ homeostasis in human health and disease. | EMBO Mol Med | 2021 | https://conductscience.org/library/papers/34041853 | PubMed |
| 6 | 37463842 | Host-microbiome interactions in nicotinamide mononucleotide (NMN) deamidation. | FEBS Lett | 2023 | https://conductscience.org/library/papers/37463842 | PubMed |
| 7 | 29211728 | An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. | PLoS One | 2017 | https://conductscience.org/library/papers/29211728 | PubMed |
| 8 | 38016950 | NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease. | Nat Commun | 2023 | https://conductscience.org/library/papers/38016950 | PubMed |
| 9 | 29239170 | Best-Matched Internal Standard Normalization in Liquid Chromatography-Mass Spectrometry Metabolomics Applied to Environmental Samples. | Anal Chem | 2018 | https://conductscience.org/library/papers/29239170 | PubMed |
| 10 | 31278280 | Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. | Sci Rep | 2019 | https://conductscience.org/library/papers/31278280 | PubMed |
| 11 | 2146924 | Importance of nicotinamide as an NAD precursor in the human erythrocyte. | Arch Biochem Biophys | 1990 | https://conductscience.org/library/papers/2146924 | PubMed |
| 12 | 36476934 | NAD precursors cycle between host tissues and the gut microbiome. | Cell Metab | 2022 | https://conductscience.org/library/papers/36476934 | PubMed |
| 13 | 36897780 | Source of nicotinamide governs its metabolic fate in cultured cells, mice, and humans. | Cell Rep | 2023 | https://conductscience.org/library/papers/36897780 | PubMed |
| 14 | 28492237 | Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. | Nat Commun | 2017 | https://conductscience.org/library/papers/28492237 | PubMed |
| 15 | 26499134 | Extracting Accurate Precursor Information for Tandem Mass Spectra by RawConverter. | Anal Chem | 2015 | https://conductscience.org/library/papers/26499134 | PubMed |
| 16 | 26118927 | NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. | Cell Metab | 2015 | https://conductscience.org/library/papers/26118927 | PubMed |
| 17 | 30127395 | De novo NAD+ biosynthetic impairment in acute kidney injury in humans. | Nat Med | 2018 | https://conductscience.org/library/papers/30127395 | PubMed |
| 18 | 30725213 | Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study. | Eur J Nutr | 2020 | https://conductscience.org/library/papers/30725213 | PubMed |
| 19 | 36300620 | KEGG for taxonomy-based analysis of pathways and genomes. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/36300620 | PubMed |
| 20 | 38176457 | B-Group Vitamins as Potential Prebiotic Candidates: Their Effects on the Human Gut Microbiome. | J Nutr | 2024 | https://conductscience.org/library/papers/38176457 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983021 | Whole-blood NAD levels track cardiovascular disease but not chronological age. | Nat Metab | 2026 | https://conductscience.org/library/papers/42983021 | PubMed |
| 42909325 | Mitochondrial remodeling in heart failure with reduced ejection fraction. | Front Physiol | 2026 | https://conductscience.org/library/papers/42909325 | PubMed |
| 42774067 | Domain-specific effects of NAD+ precursors on fatigue and functional performance: a systematic review and network meta-analysis. | Front Nutr | 2026 | https://conductscience.org/library/papers/42774067 | PubMed |
| 42744962 | Association between whole-blood NAD+ concentration and frailty in community-dwelling older adults: the Itabashi Longitudinal Study on Aging. | Geroscience | 2026 | https://conductscience.org/library/papers/42744962 | PubMed |
| 42706321 | Strengthening muscle for healthy ageing: innovative treatments for sarcopenia. | Nat Rev Drug Discov | 2026 | https://conductscience.org/library/papers/42706321 | PubMed |
| 42684362 | Protective Effects of Molecular Hydrogen on Noise-Induced Auditory and Cognitive Dysfunction. | Noise Health | 2026 | https://conductscience.org/library/papers/42684362 | PubMed |
| 42530810 | Oral LNAD+ rapidly elevates whole blood intracellular NAD and metabolic flux without elevating plasma NAD: evidence from a randomized controlled trial. | Geroscience | 2026 | https://conductscience.org/library/papers/42530810 | PubMed |
| 42514320 | Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. | Nutrients | 2026 | https://conductscience.org/library/papers/42514320 | PubMed |
| 42510902 | Nicotinamide Improves Skin Photoaging in Mice by Delaying Cellular Senescence and Suppressing the Senescence-Associated Secretory Phenotype. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42510902 | PubMed |
| 42509766 | Mitochondrial Dysfunction in Circulating Blood Cells and Biological Aging: A Review of Mechanisms and Evidence. | Biomolecules | 2026 | https://conductscience.org/library/papers/42509766 | PubMed |
| 42489969 | NAD⁺ biology and supplementation: From mechanisms to clinical perspectives. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42489969 | PubMed |
| 42478598 | A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42478598 | PubMed |
| 42304075 | Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men. | Sci Rep | 2026 | https://conductscience.org/library/papers/42304075 | PubMed |
| 42145595 | Tryptophan pathway metabotypes associate with disease activity and immune-metabolic dysfunction in inflammatory bowel disease. | medRxiv | 2026 | https://conductscience.org/library/papers/42145595 | PubMed |
| 42135540 | Whole-blood NAD+ levels do not reflect healthy ageing. | Nat Metab | 2026 | https://conductscience.org/library/papers/42135540 | PubMed |
| 42107767 | Nutrition Information Briefs - Niacin. | Adv Nutr | 2026 | https://conductscience.org/library/papers/42107767 | PubMed |
| 41944220 | Double-Pronged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration. | Aging Cell | 2026 | https://conductscience.org/library/papers/41944220 | PubMed |
| 41920466 | Metabolic Flux Adaptations During GLP-1 Receptor Agonist Therapy: Redox Implications. | Curr Obes Rep | 2026 | https://conductscience.org/library/papers/41920466 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BST1 | 683 | PubTator's text mining | https://conductscience.org/library/genes/683 | NCBI Gene |
| CD38 | 952 | PubTator's text mining | https://conductscience.org/library/genes/952 | NCBI Gene |
| FFAR2 | 2867 | PubTator's text mining | https://conductscience.org/library/genes/2867 | NCBI Gene |
| FFAR3 | 2865 | PubTator's text mining | https://conductscience.org/library/genes/2865 | NCBI Gene |
| HCAR2 | 338442 | PubTator's text mining | https://conductscience.org/library/genes/338442 | NCBI Gene |
| PNP | 4860 | PubTator's text mining | https://conductscience.org/library/genes/4860 | NCBI Gene |
| STAC3 | 246329 | PubTator's text mining | https://conductscience.org/library/genes/246329 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41540253
GET https://conductscience.org/api/papers/v1/41540253/references?page=2